Literature DB >> 18321991

The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling.

Wook Kim1, Yong Seok Kang, Jin Soo Kim, Nah-Young Shin, Steven K Hanks, Woo Keun Song.   

Abstract

Reciprocal cooperative signaling by integrins and growth factor receptors at G1 phase during cell cycle progression is well documented. By contrast, little is known about the cross-talk between integrin and transforming growth factor (TGF)-beta signaling. Here, we show that integrin signaling counteracts the inhibitory effects of TGF-beta on cell growth and that this effect is mediated by p130Cas (Crk-associated substrate, 130 kDa). Adhesion to fibronectin or laminin reduces TGF-beta-induced Smad3 phosphorylation and thus inhibits TGF-beta-mediated growth arrest; loss of p130Cas abrogates these effects. Loss and gain of function studies demonstrated that, once tyrosine-phosphorylated via integrin signaling, p130Cas binds to Smad3 and reduces phosphorylation of Smad3. That in turn leads to inhibition of p15 and p21 expression and facilitation of cell cycle progression. Thus, p130Cas-mediated control of TGF-beta/Smad signaling may provide an additional clue to the mechanism underlying resistance to TGF-beta-induced growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321991      PMCID: PMC2366878          DOI: 10.1091/mbc.e07-10-0991

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  40 in total

Review 1.  Controlling TGF-beta signaling.

Authors:  J Massagué; Y G Chen
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 2.  TGF-beta signaling: positive and negative effects on tumorigenesis.

Authors:  Lalage M Wakefield; Anita B Roberts
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

Review 3.  Functions of the adapter protein Cas: signal convergence and the determination of cellular responses.

Authors:  A H Bouton; R B Riggins; P J Bruce-Staskal
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

4.  Networks and crosstalk: integrin signalling spreads.

Authors:  Martin A Schwartz; Mark H Ginsberg
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

5.  Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines.

Authors:  Laura Moro; Laura Dolce; Sara Cabodi; Elena Bergatto; Elisabetta Boeri Erba; Monica Smeriglio; Emilia Turco; Saverio Francesco Retta; Maria Gabriella Giuffrida; Mascia Venturino; Jasminka Godovac-Zimmermann; Amedeo Conti; Erik Schaefer; Laura Beguinot; Carlo Tacchetti; Paolo Gaggini; Lorenzo Silengo; Guido Tarone; Paola Defilippi
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

Review 6.  Specificity and versatility in tgf-beta signaling through Smads.

Authors:  Xin-Hua Feng; Rik Derynck
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

7.  Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells.

Authors:  S Kook; S R Shim; S J Choi; J Ahnn; J I Kim; S H Eom; Y K Jung; S G Paik; W K Song
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

8.  A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1.

Authors:  X Liu; A E Elia; S F Law; E A Golemis; J Farley; T Wang
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 9.  Regulation of cell proliferation by Smad proteins.

Authors:  Peter Ten Dijke; Marie-José Goumans; Fumiko Itoh; Susumu Itoh
Journal:  J Cell Physiol       Date:  2002-04       Impact factor: 6.384

Review 10.  Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer.

Authors:  M Kretzschmar
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

View more
  32 in total

Review 1.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 2.  Noncanonical TGF-β signaling during mammary tumorigenesis.

Authors:  Jenny G Parvani; Molly A Taylor; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-31       Impact factor: 2.673

3.  Nmp4/CIZ inhibits mechanically induced beta-catenin signaling activity in osteoblasts.

Authors:  Zhouqi Yang; Joseph P Bidwell; Suzanne R Young; Rita Gerard-O'Riley; Haifang Wang; Fredrick M Pavalko
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

4.  Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.

Authors:  Bo Deng; Zhifu Sun; Wampfler Jason; Ping Yang
Journal:  Ann Surg Oncol       Date:  2013-08-01       Impact factor: 5.344

Review 5.  The extracellular matrix modulates the hallmarks of cancer.

Authors:  Michael W Pickup; Janna K Mouw; Valerie M Weaver
Journal:  EMBO Rep       Date:  2014-11-08       Impact factor: 8.807

6.  Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.

Authors:  Michael S Guerrero; J Thomas Parsons; Amy H Bouton
Journal:  Genes Cancer       Date:  2012-05

Review 7.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

8.  Nmp4/CIZ: road block at the intersection of PTH and load.

Authors:  Paul Childress; Alexander G Robling; Joseph P Bidwell
Journal:  Bone       Date:  2009-09-18       Impact factor: 4.398

9.  Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.

Authors:  Yuan Miao; Liang Wang; Yang Liu; Ai-Lin Li; Shu-Li Liu; Hong-Yi Cao; Xiu-Peng Zhang; Gui-Yang Jiang; Di Liu; En-Hua Wang
Journal:  Tumour Biol       Date:  2012-09-23

10.  Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.

Authors:  H Kang; C Kim; H Lee; J G Rho; J-W Seo; J-W Nam; W K Song; S W Nam; W Kim; E K Lee
Journal:  Cell Death Differ       Date:  2015-09-04       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.